AMANDA SQUIERS: Open Payments
NPI 1184860983 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,239 in 36 payments from 10 companies in 2025. Trend: 2023 $4,746 · 2024 $18,177 · 2025 $6,239
Consulting: $3,959Travel & lodging: $1,302Food & beverage: $869Speaker / faculty: $109
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 20 | $5,885 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Dendreon Pharmaceuticals LLC | 2 | $60 |
| ABBVIE INC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $32 |
| COLOPLAST CORP | 2 | $32 |
| ACCORD HEALTHCARE, INC. | 1 | $19 |
| Endo USA, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: Axonics, PROVENGE, BOTOX, GEMTESA, ORGOVYX, Nubeqa, ERLEADA, Luja Coude.
Industry payments across NV — which companies pay providers there.
